1 - Immuno Tables1
1 - Immuno Tables1
1 - Immuno Tables1
Adverse affects
Nephrotoxicity Hepatotoxicity. Hypertension and hyperlipidemia. Infections (viral). Hyperkalemia. Lymphoma and cancer. Glucose intolerance (diabetes). Anaphylacticreaction. Neurotoxicity Hirsutism. Gingival hyperplasia. -More nephrotoxic, neurotoxic -Post-transplant insulin dependent diabetes mellitus -like those of cyclosporine except it doesnt cause hirsutism or gingival hyperplasia.
Cyclosporine
Tacrolimus
Prevention of rejection of liver and kidney transplants moderate to severe atopic dermatitis organ transplantation for women
Drug
Mechanism of action
Pharmacokinetics
uses
Adverse effects
Hyperlipidemia Pneumonitis
Sacrolimus
-Taken orally fat meals can its absorption -Extensively bound to BP -Eiminated mainly in feces
Myelosuppression -Prevention of rejection of renal transplant -Hematopoietic stem cell transplant -Used in cardiology Hepatoxicity Diarrhea Hypertension. Leucopenia Thrombocytopenia
Mycophenolate mofetil
-Taken orally -Hydrolyzed in GIT into mycophenolic acid (MPA) -Glucuronidated in liver -Excreted in urine. Oral Widely distributed Metabolized in the liver Excreted by the kidney
- Solid organ transplant alternative drug to cyclosporine and tacrolimus - Lupus nephritis, rheumatoid arthritis - As replacement of azathioprine or cyclophosphamide for autoimmune diseases -Severe rheumatoid arthritis. -Non-responding atopic dermatitis. -Can be used for glomerulonephtitis, SLE, Crohns disease and multiple sclerosis. -Maintenance of renal allograft and other transplantations.
- Pain - Diarrhea - Sepsis - Leukopenia - Lymphoma -Severe bone marrow suppression -Hypersensitivity -Hepatic dysfunction -It is not teratogenic but can be carcinogenic
Azathioprine
Drug
Leflunomide
Mechanism of action
Inhibitor of Pyrimidine synthesis rather than purine
Destroys proliferating lymphoid cells & alkylate some resting cells (very toxic).
Pharmacokinetics
Orally active
Uses
Used only for rheumatoid arthritis It was the drug of choice for treatment of many autoimmune diseases,
Adverse effects
Alopecia increase LFT, nephrotoxicity, teratogenicity
Pancytopenic, heamorgenic cystitis, Infertility. Chill.
Cyclophosphamide
Antithymocyte globulins
The antibodies bind to T-lymphocytes antibodies-bound cells are phagocytosed in the liver and spleen lymphopenia and impaired T-cells responses.
Hyperacute phase of allograft rejection prepare the recipient to the transplantation of bone marrow
Has no antigenicity I.V injection extensively metabolized and eliminated predominantly in bile
Refractory ITP Acute rejection of renal , cardiac & hepatic allograft prior to transplantation of bone marrow
Drug
Basiliximab Dacilizumab Rho (D) immunoglobulin microdose
Mechanism of action
bind to -chain of the IL-2 receptor on activated T-cells leading to loss of any antigenic stimulus to activate the T-cell response system. Suppress mothers own antibody response to the foreign Rho (D) positive cells she has no memory B-cells that can be activated upon subsequent pregnancies with a Rho (D) positive fetus
Kinetics
Given I .V T 1/2 = 7 days Given I .V T 1/2 = 20 days
uses
Acute rejection in renal transplantation
Adverse effects
- GIT problems - No clinically relavant antibodies to the drugs have been detected -Malignancy not a problem Pain at the site of injection Fever
2 ml intramuscularly
Corticosteroids
At biochemical level: act on gene expression, which lead to decrease synthesis of prostaglandins, leukotrienes, cytokines and other signaling molecules that participate in immune response. At the cellular level: they inhibit the proliferation of T lymphocytes (cell mediated) and slightly dampen humoral immunity (by increasing the catabolism of immunoglobulins). At immunosuppressive doses: Corticosteroids are cytotoxic and continuous use lowers IgG.
- In combination with other immunossppressants for transplanted patients (To prepare the patients as well as maintenance). - To treat acute rejection episodes (high doses) - To treat undesirable immunoreactions (to drugs or asthma). -To autoimmune diseases (Idiopathic thrombocytopenic purpra, inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus and glomerulonephritis)